Clinical manifestation of small-for-gestational-age risk pregnancy from smoking is gestational age dependent

Kerri Fitzgerald1, Jinwen Cai, Gerald Hoff

  • 1Children's Mercy Hospitals and Clinics, Kansas City, MO 64108, US.

To determine the gestational age period at which small-for-gestational-age (SGA) risk from pregnancy smoking manifests, we conducted a retrospective cohort study of 266,782 live births in Kansas City, Missouri, from 1990 to 2004. Information was obtained from birth records. Newborns were stratified by gestation (< 32, 32 to 36, and > or = 37 weeks) and maternal pregnancy smoking. The outcome of interest was SGA. Covariates included factors associated with fetal growth restriction. SGA rates varied (8.4% versus 15.7% versus 9.9%), and relative risk from smoking increased (1.01 versus 1.46 versus 2.22) with gestational age periods. On multivariable logistic regression, smoking increased the odds ratio (OR) of SGA only among infants > or = 32 weeks; OR (95% confidence interval [CI], 1.26 [0.94, 1.68], 1.78 [1.59, 1.99], and 2.62 [2.52, 2.72]), for < 32, 32 to 36, and > or = 37 weeks, respectively. In conclusion, the clinical manifestation of SGA risk from smoking is gestational age dependent, only becoming apparent after 32 weeks of gestation.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...